Veracyte Inc
Veracyte Inc (VCYT) Straddle
VCYT straddle scan found 18 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 52.0%.
Read more
Trading a VCYT straddle lets you take a pure volatility position on Veracyte Inc without committing to a direction. Veracyte Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate VCYT straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on VCYT profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Veracyte Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the VCYT straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis.
It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the VCYT straddle is the cleanest expression of that view. Our scanner prices every VCYT straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a VCYT straddle into a catalyst or short a VCYT straddle to harvest decay, the options straddle setups that matter are all in one place.
| Mar 19, 2027 | 65.00 | $24.85 | 177 | 36% | 52.0% | $89.85 | $40.15 | 0 |
| Oct 16, 2026 | 45.00 | $4.68 | 23 | 36% | 51.1% | $49.68 | $40.33 | 6 |
| Mar 19, 2027 | 60.00 | $21.20 | 177 | 36% | 51.0% | $81.20 | $38.80 | 0 |
| Mar 19, 2027 | 55.00 | $18.80 | 177 | 36% | 47.7% | $73.80 | $36.20 | 2 |
| Dec 18, 2026 | 50.00 | $11.90 | 86 | 36% | 46.7% | $61.90 | $38.10 | 8 |
| Dec 18, 2026 | 55.00 | $15.58 | 86 | 36% | 45.2% | $70.58 | $39.43 | 8 |
| Nov 20, 2026 | 50.00 | $10.68 | 58 | 36% | 44.5% | $60.68 | $39.33 | 0 |
| Dec 18, 2026 | 45.00 | $10.33 | 86 | 36% | 44.0% | $55.33 | $34.68 | 11 |
| Mar 19, 2027 | 50.00 | $17.15 | 177 | 36% | 43.2% | $67.15 | $32.85 | 10 |
| Oct 16, 2026 | 35.00 | $9.63 | 23 | 36% | 42.9% | $44.63 | $25.38 | 20 |
As of September 23, 2026
Find the right straddle before volatility moves
Track VCYT straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→